NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong announce the commencement of an investigation concerning whether Roche Holding AG ("Roche Holding") (OTCMKTS:RHHBY) violated federal securities laws.
Click here to learn about the case: http://docs.wongesq.com/JAG-Info-Request-Form-1618. There is no cost or obligation to you.
On June 5, 2017, news reports stated that a new study showed that adding Roche Holding’s breast cancer drug Perjeta to its older treatment Herceptin only had a slight benefit while more than doubling the one-year treatment cost; and that the combination of Perjeta with Herceptin had higher rates of certain side effects than Herceptin alone.
To learn more about the investigation of Roche Holding contact Vincent Wong, Esq. either via email firstname.lastname@example.org, by telephone at 212.425.1140, or visit http://docs.wongesq.com/RHHBY-Info-Request-Form-1619.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.